GLP1R and diabetic retinopathy: Understanding the effects of SGLT2i and GLP1-ra on diabetic retinopathy and DMO may delineate phenotypes and thus allow for risk stratification for the development of strategies to tackle wider diabetic (macro- and microvascular) complications.